- significant decrease in metabolite production in patients with liver disease for CYP2C19 (p < 0.001), 2E1 (p = 0.0081), 1A2 (p = 0.0054) and 2D6 (p = 0.0110). This evidence concerns the gene CYP2C19 and liver disorder.